viru
due
long
window
period
vaccin
hepat
b
viru
reduc
risk
rare
virus
diseas
includ
west
nile
viru
herpesvirus
parvoviru
variant
creutzfeldtjakob
diseas
sever
acut
respiratori
syndrom
current
standard
test
detect
infect
nevertheless
viral
transmiss
via
blood
compon
rare
blood
group
routin
test
donor
recipi
abo
rh
system
abo
blood
group
determin
antia
andor
antib
immunoglobulin
igm
alloantibodi
recipi
serum
produc
rapid
hemolysi
donor
red
cell
commerci
avail
antia
antib
antibodi
use
determin
abo
blood
type
igm
molecul
bind
group
b
group
red
cell
antigen
respect
produc
direct
macroscop
agglutin
moreov
incub
recipi
serum
commerci
avail
group
group
b
red
cell
demonstr
presenc
specifi
c
alloantibodi
confi
rming
abo
blood
type
exampl
blood
type
show
recipi
red
cell
agglutin
commerci
antia
antibodi
commerci
group
red
cell
agglutin
recipi
serum
commerci
avail
modifi
ed
antirh
immunoglobulin
g
igg
directli
agglutin
macroscop
visibl
dposit
rh
red
blood
cell
rh
blood
group
determin
antigen
major
determin
rh
system
strong
immunogen
produc
antid
antibodi
rhneg
recipi
rhneg
woman
immun
antigen
transfus
pregnanc
risk
deliv
newborn
sever
hemolysi
thu
individu
rhneg
especi
femal
childbear
age
requir
rhneg
blood
platelet
prevent
rh
sensit
rhneg
recipi
decis
stay
rhneg
blood
versu
switch
rhposit
compon
base
anticip
need
futur
red
blood
cell
rbc
transfus
avail
rhneg
compon
urgenc
transfus
rhneg
patient
soon
becom
appar
rhneg
patient
blood
product
obtain
medic
use
donat
healthi
volunt
feder
state
regul
donat
blood
test
infecti
diseas
marker
syphili
hepat
b
surfac
human
immunodefi
cienci
viru
type
antigen
hepat
b
core
human
tcell
lymphotrop
viru
type
ii
htlvi
htlvii
hepat
c
hiv
type
antibodi
polymeras
chain
reaction
perform
hiv
hepat
c
viru
risk
miss
detect
infecti
agent
occur
window
period
exposur
posit
test
high
risk
especi
involv
hepat
b
chapter
receiv
massiv
transfus
patient
blood
volum
hour
blood
volum
estim
mlkg
preterm
neonat
mlkg
term
neonat
mlkg
children
month
age
exceed
rhneg
blood
inventori
patient
switch
rhposit
compon
problem
give
oposit
red
cell
immedi
without
antibodi
screen
emerg
potenti
develop
hemolyt
transfus
patient
antid
antibodi
detect
blood
group
antibodi
isoagglutinin
direct
nonabo
blood
group
antigen
also
perform
prior
blood
transfus
antibodi
screen
test
perform
use
recipi
serum
panel
group
rbc
known
antigen
composit
term
antibodi
screen
test
sometim
use
synonym
term
indirect
antiglobulin
coomb
test
iat
test
posit
hemolysi
agglutin
test
determin
specifi
c
antibodi
perform
iat
perform
incub
recipi
serum
c
commerci
avail
red
blood
cell
known
antigen
type
unbound
antibodi
remov
wash
rbc
nacl
antiglobulin
reagent
rabbit
antihuman
igg
igg
plu
complement
ad
posit
test
show
red
cell
agglutin
refl
ect
presenc
alloor
autoantibodi
alloversu
autoantibodi
determin
commerci
avail
panel
red
cell
vari
antigen
phenotyp
agglutin
red
cell
panel
indic
autoantibodi
eg
patient
autoimmun
hemolyt
anemia
contrast
specifi
c
reactiv
indic
alloantibodi
eg
patient
alloimmun
direct
antiglobulin
coomb
test
detect
antibodi
complement
surfac
red
cell
wash
recipi
red
cell
incub
antiglobulin
reagent
rabbit
antihuman
igg
igg
plu
complement
iat
agglutin
observ
antibodi
complement
present
surfac
red
cell
crossmatch
aboand
rhcompat
unit
blood
determin
whether
recipi
serum
contain
unexpect
antibodi
donor
red
cell
antigen
whenev
red
cell
product
request
abo
rh
type
antibodi
screen
full
crossmatch
routin
perform
antibodi
screen
neg
patient
may
transfus
appropri
aborh
type
immedi
spin
crossmatch
mix
patient
serum
rbc
unit
select
transfus
observ
hemolysi
agglutin
provid
ad
safeti
antibodi
screen
posit
specifi
citi
antibodi
identifi
ed
clinic
signifi
cant
red
cell
neg
relev
antigen
transfus
full
crossmatch
also
perform
addit
time
requir
identifi
antibodi
fi
nd
antigenneg
red
cell
perform
full
crossmatch
test
may
take
hour
day
multipl
antibodi
present
tabl
emerg
situat
blood
may
need
transfus
standard
test
complet
circumst
physician
ask
sign
emerg
releas
form
document
reason
urgent
need
acknowledg
blood
fulli
crossmatch
time
transfus
oneg
red
cell
avail
immedi
transfus
patient
use
patient
blood
type
known
time
determin
situat
sometim
occur
set
trauma
appli
fi
rst
unit
transfus
pack
red
blood
cell
prbc
transfus
use
improv
blood
oxygencarri
capac
restor
blood
volum
unit
prepar
whole
blood
remov
plasma
produc
averag
hematocrit
valu
procedur
reduc
transfus
volum
isoagglutinin
load
unit
usual
contain
approxim
ml
rbc
ml
plasma
ml
addit
nutrient
solut
eg
citrat
anticoagul
phosphat
dextros
atp
clinic
citrat
toxic
hypocalcemia
due
calcium
chelat
rare
occur
massiv
transfus
eg
exchang
transfus
respond
calcium
supplement
prolong
storag
produc
leakag
potassium
plasma
usual
clinic
insignifi
cant
blood
infus
fi
lter
remov
debri
caus
storag
transfus
usual
given
symptom
anemia
blood
loss
sever
delay
might
result
signifi
cant
disabl
death
select
indic
transfus
includ
acut
bleed
highdos
chemotherapi
sever
prematur
sickl
cell
diseas
eg
splenic
sequestr
sever
acut
chest
syndrom
thalassemia
major
aplast
anemia
pure
red
cell
aplasia
sever
autoimmun
hemolyt
anemia
use
compat
unit
transfus
mlkg
prbc
child
rais
hemoglobin
concentr
gdl
hematocrit
tabl
transfus
usual
given
mlkg
hour
faster
transfus
may
necessari
replac
acut
blood
loss
intent
transfus
small
amount
eg
infant
unit
divid
sever
aliquot
leukocytereduc
prbc
prepar
pass
unit
fi
lter
remov
white
blood
cell
procedur
frequent
perform
time
blood
collect
type
product
produc
fewer
nonhemolyt
febril
reaction
mediat
antibodi
donor
white
cell
antigen
well
cytokin
produc
compon
storag
product
also
produc
less
alloimmun
viral
eg
cytomegaloviru
transmiss
indic
patient
need
chronic
transfus
eg
children
chemotherapi
hemoglobinopathi
prior
exposur
blood
antigen
eg
multipar
femal
irradi
prbc
prepar
expos
unit
cgi
radiat
treatment
inactiv
donor
cell
reduc
risk
graftversushost
reaction
recipi
type
product
recommend
immunecompromis
patient
eg
children
chemotherapi
wash
prbc
prepar
wash
red
cell
nacl
remov
plasma
type
product
use
patient
sever
allerg
reaction
eg
cough
wheez
swollen
lip
urticaria
transfus
despit
antihistamin
administr
immunoglobulin
e
antibodi
donor
plasma
protein
mediat
advers
reaction
product
also
use
patient
immunoglobulin
iga
defi
cienci
develop
iga
antibodi
platelet
princip
mediat
hemostasi
constantli
requir
support
endotheli
function
bleed
eg
petechia
epistaxi
melena
hematemesi
menorrhagia
hematuria
common
platelet
count
less
moreov
lifethreaten
hemorrhag
eg
airway
lung
central
nervou
system
gastrointestin
tract
becom
like
platelet
count
less
thu
profound
thrombocytopenia
defi
ned
platelet
count
due
decreas
product
eg
patient
chemotherapi
aplast
anemia
promptli
treat
platelet
transfus
prophylact
transfus
recommend
platelet
count
less
therapeut
transfus
contrast
given
treat
signifi
cant
bleed
even
platelet
count
greater
platelet
concentr
prepar
routin
donat
whole
blood
centrifug
produc
plateletrich
plasma
centrifug
separ
supernat
plasma
yield
platelet
concentr
unit
ml
singl
unit
prepar
unit
whole
blood
contain
greater
platelet
rais
platelet
count
mm
adult
transfus
pool
randomdonor
unit
platelet
adult
children
greater
kg
kg
children
kg
rais
platelet
count
mm
see
tabl
usual
adequ
support
hemostasi
see
tabl
platelet
also
prepar
blood
singl
donor
use
blood
cell
separ
machin
yield
platelet
product
apheresi
equival
random
unit
adult
children
greater
kg
platelet
transfus
requir
singledonor
apheresi
unit
mlkg
children
kg
see
tabl
type
product
apheresi
unit
platelet
aim
minim
donor
exposur
recommend
patient
requir
chronic
transfus
intent
transfus
small
volum
eg
infant
apheresi
unit
platelet
divid
two
aliquot
platelet
surviv
normal
day
shorter
patient
profound
thrombocytopenia
platelet
normal
consum
spleen
blood
vessel
alloimmun
fever
infect
splenomegali
abocompat
singledonor
apheresi
leukocytedeplet
irradi
platelet
less
like
produc
alloimmun
therefor
recommend
patient
requir
chronic
transfus
indic
leukocytedeplet
irradi
product
discuss
prbc
transfus
platelet
transfus
recommend
patient
hemolyticurem
syndrom
thrombot
thrombocytopen
purpura
heparininduc
thrombocytopenia
idiopath
thrombocytopen
purpura
medic
could
inhibit
platelet
function
eg
salicyl
nonsteroid
antiinfl
ammatori
drug
avoid
thrombocytopen
patient
fresh
frozen
plasma
ffp
prepar
whole
blood
frozen
less
c
within
hour
collect
procedur
preserv
activ
labil
protein
factor
v
vii
nonconcentr
sourc
clot
factor
use
acquir
coagulopathi
eg
liver
diseas
dissemin
intravascular
coagul
rapid
revers
warfarin
congenit
coagul
factor
defi
cienci
eg
factor
ii
x
xi
xiii
thrombot
thrombocytopen
purpura
hemolyticurem
syndrom
see
chapter
acut
childhood
immun
thrombocytopen
purpura
relat
platelet
disord
chapter
hemolyticurem
syndrom
dose
rang
mlkg
repeat
necessari
see
tabl
product
abo
compat
potenti
complic
includ
viral
transmiss
eg
hiv
hepat
anaphylact
reaction
urticaria
alloimmun
risk
viral
transmiss
ffp
use
absolut
necessari
cryoprecipit
prepar
ffp
thaw
c
precipit
suspend
ml
plasma
refrozen
less
c
rich
fi
brinogen
unit
contain
approxim
mg
factor
viii
von
willebrand
factor
use
treat
bleed
due
fi
brinogen
defi
cienci
sever
liver
diseas
dissemin
intravascular
coagul
afi
brinogenemia
rare
recommend
dose
unit
bag
per
kg
unit
adult
rais
plasma
fi
brinogen
mgdl
see
tabl
due
risk
viral
transmiss
avail
safer
product
cryoprecipit
use
treat
patient
hemophilia
von
willebrand
diseas
abo
incompat
produc
sever
immunemedi
hemolyt
reaction
antia
andor
antib
igm
alloantibodi
recipi
plasma
produc
intravascular
hemolysi
circul
rbc
fragment
hemoglobinemia
hemoglobinuria
donor
rbc
symptom
includ
rigor
headach
fever
chest
tight
fl
ank
pain
redblack
urin
hypotens
nausea
vomit
seriou
progress
may
fatal
due
shock
organ
failur
manag
includ
immedi
stop
transfus
administ
isoton
fl
uid
nacl
mannitol
gkg
intraven
induc
diuresi
care
monitor
respiratori
circulatori
statu
urin
output
urin
color
support
care
intraven
fl
uid
diuret
oxygen
appropri
consult
blood
bank
nephrolog
hematolog
necessari
blood
bag
blood
sampl
recipi
return
blood
bank
retyp
nonimmun
hemolyt
reaction
occur
rbc
damag
prior
transfus
eg
expos
improp
temperatur
ship
storag
mishandl
transfus
hemoglobinemia
hemoglobinuria
present
recipi
without
symptom
complic
requir
treatment
febril
reaction
caus
cytokin
produc
donor
leukocyt
accumul
store
blood
molecul
produc
fever
rigor
tachycardia
dyspnea
manag
consist
stop
transfus
exclud
hemolyt
transfus
reaction
repeat
crossmatch
unit
blood
perform
coomb
test
symptom
usual
subsid
within
minut
stop
transfus
premed
acetaminophen
usual
help
allerg
symptom
rash
urticaria
pruritu
fl
ush
rare
angioedema
follow
recipi
exposur
donor
plasma
protein
substanc
eg
medic
taken
donor
reaction
amelior
premed
diphenhydramin
mgkg
methylprednisolon
mgkg
sever
form
allerg
reaction
anaphylact
occur
recipi
iga
defi
cient
manag
urticaria
consist
discontinu
transfus
administ
diphenhydramin
methylprednisolon
anaphylaxi
requir
intraven
fl
uid
steroid
subcutan
intraven
epinephrin
administr
depend
upon
sever
transfusionrel
acut
lung
injuri
noncardiogen
pulmonari
edema
associ
passiv
transfus
donor
granulocyt
antibodi
reaction
occur
donor
antileukocyt
antibodi
eg
multipar
previous
transfus
donor
react
recipi
leukocyt
aggreg
activ
lung
microvasculatur
produc
alter
vascular
permeabl
pulmonari
capillari
leak
syndrom
resembl
acut
respiratori
distress
syndrom
ard
manag
similarli
ard
circulatori
overload
cough
precordi
pain
tachycardia
tachypnea
dyspnea
hypoxia
may
follow
rapid
transfus
complic
common
patient
cardiac
renal
diseas
hypertens
profound
anemia
hemoglobin
concentr
gdl
treatment
includ
stop
transfus
oxygen
supplement
administr
furosemid
mgkg
intraven
volum
overload
avoid
transfus
half
desir
transfus
hour
follow
administr
intraven
furosemid
mgkg
follow
second
half
transfus
hour
rare
acut
complic
includ
bacteri
contamin
notabl
platelet
transfus
citrateinduc
hypocalcemia
hyperkalemia
due
ruptur
red
cell
viral
contamin
cytomegaloviru
hiv
hepat
b
c
viru
remain
seriou
complic
posttransfus
hepat
particular
concern
donor
usual
asymptomat
risk
hiv
transmiss
almost
neglig
probabl
million
transfus
alloimmun
develop
alloantibodi
red
cell
platelet
leukocyt
antigen
result
multipl
exposur
donor
antigen
everi
transfus
potenti
induc
alloimmun
posttransfus
graftversushost
reaction
occur
patient
chemotherapi
immunodefi
cienci
also
occur
newborn
young
infant
receiv
transfus
blood
rel
donor
cell
attack
recipi
tissu
produc
skin
rash
increas
transaminas
diarrhea
gamma
irradi
blood
compon
elimin
risk
iron
overload
result
repeat
prbc
transfus
longterm
complic
hemochromatosi
includ
cirrhosi
fi
brosi
pancrea
cardiomyopathi
chelat
therapi
deferoxamin
mesyl
desferol
necessari
patient
receiv
longterm
transfus
viral
transmiss
transfus
occur
rare
risk
develop
acquir
immunodefi
cienci
syndrom
blood
transfus
almost
neglig
nevertheless
risk
receiv
transfus
alway
outweigh
potenti
advers
effect
seriou
transfus
reaction
avoid
verifi
patient
identif
blood
group
recipi
donor
blood
compon
transfus
slowli
fi
rst
minut
patient
close
monitor
diphenhydramin
mgkg
methylprednisolon
mgkg
acetaminophen
given
minor
allerg
andor
febril
reaction
medic
also
use
prophylaxi
patient
prior
advers
reaction
transfus
leukocytereduc
irradi
blood
compon
produc
less
advers
reaction
